Bertrand Sauvageon

Part time supporting the company on business development, fundraising and partnership activities. Advisor to the Executive Chairman

Drove the transformation of Hello Health Group from a non-profitable Healthtech start-up towards a sustainable profitable business while accelerating development and launch of innovative and differentiating AI supported products and solutions for its users and for its BtoB clients to position the company for accelerated growth & profitability in 2024 & beyond

Driving global Business Development operations as well as the P&L of Indochina cluster of countries (Vietnam, Myanmar, Cambodia, Laos) for DKSH BU Healthcare

Leading DKSH Healthcare Business Unit over Vietnam, Myanmar, Cambodia and Laos.

Leading DKSH Healthcare Business Unit in Vietnam Driving organization capabilities build up toward our vision. Focusing on service innovation, cost efficiency, business development and sales and marketing excellence. Achieving above target high double digit sales growth and accelerating profit growth of a 2000+ employees market expansion services organization servicing more than 16000 in-market healthcare customers and 60 multinational manufacturing clients

Leading changes and driving improvements in the field of sales force productivity in Asia 3000 sales people over 12 countries. > Conducting diagnosis and benchmarking of SFE practices. Building awareness, sense of urgency and a leading coalition to foster change. Leading a global project and coordinating teams to build a new & common sales platform (selling model, sales competencies, coaching & performance management, Sales force training, profiling & targeting) > Driving the development and deployment of a Sales Force electronic territory management system over 6 countries and of a SF KPI and customer DB management dashboard in cooperation with IT, local leaders and third parties > Designing and deploying a new Sales Force activity KPI process. Ensuring high execution level through regular formal gap analysis and corrective actions reviews

- Member of Group Management Committee & Corporate Operations Committee - P&L full responsibility for Asia, Latin America, Middle East, and Africa - € 100 million profitable sales (from € 54 million in 2003). Double digit growth in turnover & profits; profitability achieved through optimization of organic growth, international expansion (products launches, market access), successful re-organization, subsidiaries set-up & strategic partnerships. Sales and profits targets achieved - Leading cross-functional team. Executive Committee comprises HR, Finance, Country/Area General Management, Medical, Marketing, Strategic Planning functions. 500 staff - Creating & implementing a vision & a strategic plan aligned with corporate strategy - Identifying and implementing key organizational and process changes to improve performances: cross-functional culture, Market Intelligence, resources allocation, Sales and Marketing Forces Excellence program - Successful market access in priority countries, key partnerships negotiations & reorganization of Transcontinental Operations in 2006

- Member of the International Division Management Committee - P&L full responsibility for Asia (excluding Japan & China) - Developing sales and marketing operations in Asia (excl. China & Japan) : 13 countries; € 14 millions sales; 200 staff. Growing sales and EBIT in line with targets: 12% sales CAGR from 2001 to 2003. Improving productivity: 17% EBIT CAGR from 2001 to 2003 - Improving Marketing and Sales team competencies & performances (portfolio management, regional segmentation and targeting training program, selling & coaching skills) - Optimizing partnerships terms and performances - Focusing resources to optimize sales and profitability growth

- Member of the Asia Management Committee - P&L full responsibility for Vietnam-Cambodia-Laos - Developing operations in Vietnam, Cambodia & Laos: € 3.9 millions sales; 67 staff, 3 Representative Offices - Marketing and sales of 14 pharmaceutical products - Leading a 67 people organization including 2 sales forces (Ethical: 38 and Retail: 15) and 14 marketing and support functions staff - Designing & implementing yearly budget and medium term business plan - Building a customer focused, financial performance driven, learning and attractive organization - Upgrading Marketing and Sales competencies to best-in-class level - Designing and implementing a successful Rx & OTC marketing strategy - Above target sales & EBIT growth: 98-01 sales CAGR: +22%; 99-01 EBIT CAGR: +150% - Top 4 Ipsen products becoming No1 or 2 of their therapeutic class. Bringing Ipsen from 47th to 14th position in terms of yearly sales among all pharma companies in Vietnam

A one week executive training program providing essential understanding and tools to lead people and key changes in organization processes and culture